Sponsor study identifier
observational
66
1 country
2
Study Start
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2011
Actual (reported)Study Completion
January 2011
Actual (reported)Overall Objective: The overall objective of this cross-sectional psychosocial study is to examine illness-related factors, family context factors, and child resiliency as predictors or correlates of child adjustment to leukemia treatment. Primary Objective 1: 1(a): To examine illness-related factors (i.e., child's health and physical functioning and severity of the child's illness) as predictors of child psychological adjustment to leukemia. 1(b): To examine relapse status as a grouping variable affecting child psychological adjustment to leukemia. 1(c): To examine stage of treatment as a grouping variable affecting child psychological adjustment to leukemia. Primary Objective 2:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
June 20, 2007
Actual (reported)June 21, 2007
Actual (reported)January 2011
Actual (reported)January 2011
Actual (reported)Illness-related factors as predictors of child psychological adjustment to leukemia
4 Years
Children with leukemia and their families/caregivers.
Questionnaires administered to pediatric patients and their parent(s) or caregiver(s).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Children with a diagnosis of leukemia and their parent(s) or caregiver(s).
University of Minnesota Medical Center-Twin Cities
Minneapolis, Minnesota, 55455, United States
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
Martha Askins, PhD
M.D. Anderson Cancer Center
66 participants (actual enrollment reported by the registry).
First Submitted
June 20, 2007
First Posted
June 21, 2007
Study Start
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
Erwinase Study in Patients With Acute Lymphoblastic Leukemia
Contact the study team to confirm eligibility.
Primary Completion
January 2011
Actual (reported)Study Completion
January 2011
Actual (reported)Last Updated
February 20, 2012
Record last verified: 2012-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: